OLX703A

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameOLX703A
Drug Alias NameOLX-703-AOLX-703AOLX703-A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHBsAg inhibitorsRNA interferenceAsialoglycoprotein receptor binders
TargetsHepatitis B Surface AntigensAsialoglycoprotein receptor
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOlix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmaron IncOlix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A